Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    2247119 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   Growth Disorder
Interventions: Drug: Flutamide and Testolactone;   Drug: Deslorelin

Indicates status has not been verified in more than two years